(redirected from Rosiglitazone maleate)
Also found in: Medical.


A thiazolidinedione drug, C18H19N3O3S, used in its maleate form to treat type 2 diabetes.

[rosi-, origin unknown + -glitazone, thiazolidinedione suff. (alteration of (hyper)gly(cemia) + t(hi)az(olidinedi)one).]
American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.


n rosiglitazona
English-Spanish/Spanish-English Medical Dictionary Copyright © 2006 by The McGraw-Hill Companies, Inc. All rights reserved.
Mentioned in ?
References in periodicals archive ?
Diclofenac Sodium + Misoprostol (Arthrotec 50) 50 mg/200 mcg tablet; Cetirizine 2HCl (Cetrizin) 10 mg tablet; Clindamycin (Clindacap-300) 300 mg tablet; Simvastatin (Zimmex 20) 20 mg tablet; Rosiglitazone maleate (Avandia) 4 mg tablet; Gentamicin sulfate (Gentaderm) 0.1 g/ 100 g cream;
The average difference was 73 milligrams per deciliter (mg./dL.) compared with a placebo or rosiglitazone maleate (Avandia[R]).
n Avandia (rosiglitazone maleate), prescribed to treat diabetes.
MUSCAT: Avandia (Rosiglitazone Maleate), the anti-diabetes drug produced by GlaxoSmithKline (GSK), has been withdrawn from the Omani market.
24 September 2010 - UK GlaxoSmithKline (LON: GSK) said yesterday that following a review of Avandia (rosiglitazone maleate) by the European Medicines Agency (EMA) and the US Food and Drug Administration (FDA), each agency has announced its individual regulatory decisions and the resulting actions.
Nissen and Wolski suggest that the use of rosiglitazone maleate (Avandia: GlaxoSmith Kline.
(rosiglitazone maleate and glimepiride, GlaxoSmithKline)
Avandaryl (rosiglitazone maleate and glimepiride, GlaxoSmithKline)
Subjects continued their usual doses of metformin, but the other oral agent was withdrawn during an 8-week period prior to randomization to either rosiglitazone maleate or glyburide.
Health Canada has approved Avandia (rosiglitazone maleate), a breakthrough treatment for type 2 diabetes.